Stella Chemifa Corporation (TYO:4109)
Japan · Delayed Price · Currency is JPY 5,700.00
+160.00 (2.89%)
Aug 14, 2026, 3:30 PM JST
Stella Chemifa Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 37,758 | 36,799 | 36,288 | 30,446 | 35,382 | 37,296 | |
Revenue Growth | 3.94% | 1.41% | 19.19% | -13.95% | -5.13% | 13.39% |
Cost of Revenue | 29,104 | 28,218 | 28,031 | 23,999 | 27,972 | 28,394 |
Gross Profit | 8,654 | 8,581 | 8,257 | 6,447 | 7,410 | 8,902 |
Selling, General & Admin | 3,363 | 3,310 | 3,320 | 3,026 | 3,239 | 3,574 |
Research & Development | 626 | 626 | 597 | 698 | 660 | 744 |
Operating Expenses | 3,989 | 3,936 | 3,918 | 3,724 | 3,896 | 4,324 |
Operating Income | 4,665 | 4,645 | 4,339 | 2,723 | 3,514 | 4,578 |
Interest Expense | -81 | -74 | -39 | -30 | -32 | -35 |
Interest & Investment Income | 106 | 89 | 109 | 81 | 37 | 13 |
Earnings From Equity Investments | -230 | -282 | -393 | -302 | 329 | 994 |
Currency Exchange Gain (Loss) | -74 | -56 | 102 | 337 | 283 | 102 |
Other Non Operating Income (Expenses) | 56 | 93 | 55 | 121 | 346 | 58 |
EBT Excluding Unusual Items | 4,442 | 4,415 | 4,173 | 2,930 | 4,477 | 5,710 |
Gain (Loss) on Sale of Investments | 276 | - | 263 | 104 | 1,387 | 1,182 |
Gain (Loss) on Sale of Assets | 19 | 21 | 6 | 17 | 12 | 21 |
Asset Writedown | -40 | -41 | -219 | -487 | -2,509 | -73 |
Other Unusual Items | - | - | 1 | 49 | -1 | - |
Pretax Income | 4,697 | 4,395 | 4,224 | 2,613 | 3,366 | 6,840 |
Income Tax Expense | 1,378 | 1,348 | 1,352 | 777 | 1,383 | 1,814 |
Earnings From Continuing Operations | 3,319 | 3,047 | 2,872 | 1,836 | 1,983 | 5,026 |
Minority Interest in Earnings | 5 | 11 | 20 | 9 | 297 | 338 |
Net Income | 3,324 | 3,058 | 2,892 | 1,845 | 2,280 | 5,364 |
Net Income to Common | 3,324 | 3,058 | 2,892 | 1,845 | 2,280 | 5,364 |
Net Income Growth | 14.78% | 5.74% | 56.75% | -19.08% | -57.49% | 81.28% |
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | 13 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | 13 |
Shares Change | 3.30% | -1.40% | -0.18% | -1.93% | -3.33% | -1.12% |
EPS (Basic) | 278.51 | 258.41 | 240.96 | 153.44 | 185.97 | 422.93 |
EPS (Diluted) | 278.51 | 258.41 | 240.96 | 153.44 | 185.97 | 422.93 |
EPS Growth | 14.74% | 7.24% | 57.04% | -17.49% | -56.03% | 83.34% |
Free Cash Flow | - | 1,438 | 2,950 | 841 | 1,048 | 2,701 |
Free Cash Flow Per Share | - | 121.51 | 245.79 | 69.94 | 85.48 | 212.96 |
Dividend Per Share | 170.000 | 170.000 | 170.000 | 154.000 | 60.000 | 60.000 |
Dividend Growth | 0% | 0% | 10.39% | 156.67% | 0% | 27.66% |
Gross Margin | - | 23.32% | 22.75% | 21.18% | 20.94% | 23.87% |
Operating Margin | 12.35% | 12.62% | 11.96% | 8.94% | 9.93% | 12.28% |
Profit Margin | 8.80% | 8.31% | 7.97% | 6.06% | 6.44% | 14.38% |
Free Cash Flow Margin | - | 3.91% | 8.13% | 2.76% | 2.96% | 7.24% |
EBITDA | 7,573 | 7,534 | 7,151 | 5,491 | 6,107 | 7,291 |
EBITDA Margin | - | 20.47% | 19.71% | 18.04% | 17.26% | 19.55% |
D&A For EBITDA | 2,908 | 2,889 | 2,812 | 2,768 | 2,593 | 2,713 |
EBIT | 4,665 | 4,645 | 4,339 | 2,723 | 3,514 | 4,578 |
EBIT Margin | - | 12.62% | 11.96% | 8.94% | 9.93% | 12.28% |
Effective Tax Rate | - | 30.67% | 32.01% | 29.74% | 41.09% | 26.52% |